Hotstocked Newsletters

Promoted Companies

PROMOTION HISTORY
SORT BY:

Prana Biotechnology Ltd (PRAN)

Total paid for Promotions this month: $0
E-mails this Month: 2
Estimated Volume Generated: $0
Research Report on PRAN: Click to see
* The information presented is based on information for Feb , 2014
Positive Results in Huntington Disease Study (Must Read) (Mailing list information, including unsubscription instructions, is located at the end of this message.)   Prana Biotechnology (PRAN)   Huntington's disease is an inherited disease that causes the progressive breakdown (degeneration) of nerve cells in the brain.   Symptoms of Huntington's disease usually develop between ages 30 and 50, but they can appear as early as age 2 or as late ...read more
Promoter: Crweselect.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 29.24 % Gain at close: 21.54 %
Positive Results in Huntington Disease Study (Must Read)   Prana Biotechnology (PRAN)   Huntington's disease is an inherited disease that causes the progressive breakdown (degeneration) of nerve cells in the brain.   Symptoms of Huntington's disease usually develop between ages 30 and 50, but they can appear as early as age 2 or as late as 80.   The hallmark symptom of Huntington's disease is uncontrolled movement of the arms, ...read more
Promoter: stockbling.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 29.24 % Gain at close: 21.54 %
Prana Biotechnology Limited (PRAN) Reacts Well After Announcement Last Week   Prana Biotechnology Limited (PRAN) – gained significantly last week with heavy trading last Friday. Friday PRAN  closed up 17.54% to $5.83 after after the company announced the first of several key appointments in the near term to advance PBT2 into late stage and pre-market clinical development of PBT2 as a treatment for Alzheimer’s and Huntington’s ...read more
Promoter: Crweselect.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 4.33 % Gain at close: -0.80 %
Prana Biotechnology Limited (PRAN) Reacts Well After Announcement Last Week   Prana Biotechnology Limited (PRAN) – gained significantly last week with heavy trading last Friday. Friday PRAN  closed up 17.54% to $5.83 after after the company announced the first of several key appointments in the near term to advance PBT2 into late stage and pre-market clinical development of PBT2 as a treatment for Alzheimer’s and Huntington’s ...read more
Promoter: pennyomega.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 4.33 % Gain at close: -0.80 %
Prana Biotechnology Limited (PRAN) Reacts Well After Announcement Last Week   Prana Biotechnology Limited (PRAN) – gained significantly last week with heavy trading last Friday. Friday PRAN  closed up 17.54% to $5.83 after after the company announced the first of several key appointments in the near term to advance PBT2 into late stage and pre-market clinical development of PBT2 as a treatment for Alzheimer’s and Huntington’s ...read more
Promoter: Double in stocks Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 4.33 % Gain at close: -0.80 %
Prana Biotechnology Limited (PRAN) Reacts Well After Announcement Last Week   Prana Biotechnology Limited (PRAN) – gained significantly last week with heavy trading last Friday. Friday PRAN  closed up 17.54% to $5.83 after after the company announced the first of several key appointments in the near term to advance PBT2 into late stage and pre-market clinical development of PBT2 as a treatment for Alzheimer’s and Huntington’s ...read more
Promoter: stockbling.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 4.33 % Gain at close: -0.80 %
        PRAN, Prana Biotechnology Ltd.   ** PRAN reported that The Journal Of Neurochemistry has published an update on the mechanism of action of PBT2 in the treatment of Alzheimer’s Disease (AD). The study explains how PBT2 is able to restore cognition in AD sufferers through repair of affected Alzheimer’s brains.   The findings further explain the rapid improvement in cognition previously reported ...read more
Promoter: pennyomega.com Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 8.45 % Gain at close: -9.39 %
      PRAN, Prana Biotechnology Ltd.   ** PRAN reported that The Journal Of Neurochemistry has published an update on the mechanism of action of PBT2 in the treatment of Alzheimer’s Disease (AD). The study explains how PBT2 is able to restore cognition in AD sufferers through repair of affected Alzheimer’s brains.   The findings further explain the rapid improvement in cognition previously reported in transgenic ...read more
Promoter: penny to buck Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 8.45 % Gain at close: -9.39 %
        PRAN, Prana Biotechnology Ltd.   ** PRAN reported that The Journal Of Neurochemistry has published an update on the mechanism of action of PBT2 in the treatment of Alzheimer’s Disease (AD). The study explains how PBT2 is able to restore cognition in AD sufferers through repair of affected Alzheimer’s brains.   The findings further explain the rapid improvement in cognition previously reported in transgenic ...read more
Promoter: Stock-pr Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 8.45 % Gain at close: -9.39 %
        PRAN, Prana Biotechnology Ltd.   ** PRAN reported that The Journal Of Neurochemistry has published an update on the mechanism of action of PBT2 in the treatment of Alzheimer’s Disease (AD). The study explains how PBT2 is able to restore cognition in AD sufferers through repair of affected Alzheimer’s brains.   The findings further explain the rapid improvement in cognition previously reported in transgenic ...read more
Promoter: Double in stocks Paying Party: UNKNOWN
Stocks covered: Compensation: Avg $ Volume for Period:
PRAN Unknown compensation UNKNOWN
Max Profit: 8.45 % Gain at close: -9.39 %
First  >> Last
Video not found or You must install the Flash Plugin for your Browser in order to view this movie